- Reports /
- Wound Care Management Market
Wound Care Management Market
Wound Care Management Market Research Report – Segmented By Product (Wound Care, Wound Closure), By Wound Type (Chronic Wound, Acute Wound) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Product
- By Wound Type
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Wound Care Management Market was valued at US $9.58 billion in 2021 and is projected to grow at 4.10% CAGR over the forecast period to reach US $12.19 billion by 2027. Wound Care Management Market represented US $0.74 billion opportunity over 2019-2021 and estimated to create US $2.61 billion opportunity in 2027 over 2021.
Wound Care Management from Consainsights analyses the Wound Care Management Market in the Life Sciences industry over the forecast period to 2027.
Wound Care Management research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Wound Care Management segmentation includes Product, Wound Type and Geography.
Based on the Product, the Wound Care Management analysis covers Wound Care, Wound Closure.
In Product segment, Wound Care segment has highest cagr growth of 3.64%.
Based on the Wound Type, the Wound Care Management analysis covers Chronic Wound, Acute Wound.
In Wound Type segment, Chronic Wound segment has highest cagr growth of 3.64%.
Based on the region, the Wound Care Management analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include 3M Company, B. Braun Melsungen AG, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group PLC, Integra Lifesciences, Molnlycke Health Care, Medtronic PLC, Paul Hartmann AG, Smith & Nephew and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Product
Introduction
In 2021, Wound Care segment has the highest revenue of US $6.26 billion and is expected to grow at CAGR of 3.64% by 2027 Wound Care segment has highest cagr growth of 3.64%.
Wound Care
Wound Care segment was valued at US $5.78 billion in 2019 and is projected to grow at 3.64% CAGR over the forecast period to reach US $7.97 billion by 2027. Wound Care segment represented US $0.48 billion opportunity over 2019-2021 and estimated to create US $1.71 billion opportunity in 2027 over 2021.
Wound Closure
Wound Closure segment was valued at US $3.06 billion in 2019 and is projected to grow at 3.64% CAGR over the forecast period to reach US $4.22 billion by 2027. Wound Closure segment represented US $0.26 billion opportunity over 2019-2021 and estimated to create US $0.90 billion opportunity in 2027 over 2021.
Wound Type
Introduction
In 2021, Chronic Wound segment has the highest revenue of US $7.93 billion and is expected to grow at CAGR of 3.64% by 2027 Chronic Wound segment has highest cagr growth of 3.64%.
Chronic Wound
Chronic Wound segment was valued at US $7.32 billion in 2019 and is projected to grow at 3.64% CAGR over the forecast period to reach US $10.09 billion by 2027. Chronic Wound segment represented US $0.61 billion opportunity over 2019-2021 and estimated to create US $2.16 billion opportunity in 2027 over 2021.
Acute Wound
Acute Wound segment was valued at US $1.52 billion in 2019 and is projected to grow at 3.64% CAGR over the forecast period to reach US $2.10 billion by 2027. Acute Wound segment represented US $0.13 billion opportunity over 2019-2021 and estimated to create US $0.45 billion opportunity in 2027 over 2021.